ERBB2 and exocrine pancreatic carcinoma: HER2 is also expressed in varying levels on the surface of human pancreatic carcinoma cells [22, 23], and some reports indicated that Tmab induces ADCC against human pancreatic cancer in vitro and in vivo [24–28].